Literature DB >> 1910184

Preventing secondary infections among HIV-positive persons.

G A Filice1, C Pomeroy.   

Abstract

Secondary infectious diseases contribute substantially to morbidity and mortality of people infected with human immunodeficiency virus (HIV). The authors developed comprehensive, practical recommendations for prevention of infectious complications in HIV-infected people. Recommendations are concerned with the pathogens that are more common or more severe in HIV-infected people. Several infectious complications can be prevented by avoiding ingestion of contaminated food or water. Zoonoses can be prevented by precautions to be taken in contacts with animals. The risk of several fungal diseases can be reduced if activities likely to lead to inhalation of spores are avoided. HIV-infected people should be advised how to lower adverse health effects of travel, especially international travel. The potential for infectious complications of sexual activity and illicit drug use should be stressed, and recommendations to reduce the risk are discussed. Recommendations for use of vaccines in HIV-infected people are reviewed. Blood CD4+ lymphocyte concentrations, tuberculin skin testing, Toxoplasma serology, and sexually transmitted disease screening should be performed in certain subsets of HIV-infected people. Guidelines for chemoprophylaxis against Pneumocystis carinii and tuberculosis are presented. Recent data suggest that intravenous immunoglobulin therapy may prevent bacterial infections in HIV-infected children.

Entities:  

Mesh:

Year:  1991        PMID: 1910184      PMCID: PMC1580313     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  128 in total

1.  A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia.

Authors:  L N Slater; D F Welch; D Hensel; D W Coody
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection.

Authors:  L A Perkocha; S M Geaghan; T S Yen; S L Nishimura; S P Chan; R Garcia-Kennedy; G Honda; A C Stoloff; H Z Klein; R L Goldman
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

3.  A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.

Authors:  M A Fischl; C B Parker; C Pettinelli; M Wulfsohn; M S Hirsch; A C Collier; D Antoniskis; M Ho; D D Richman; E Fuchs
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

4.  Food counseling for patients with AIDS.

Authors:  P M Griffin; R V Tauxe
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

Review 5.  Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment.

Authors:  D M Musher; R J Hamill; R E Baughn
Journal:  Ann Intern Med       Date:  1990-12-01       Impact factor: 25.391

Review 6.  Listeriosis in patients infected with human immunodeficiency virus.

Authors:  J Berenguer; J Solera; M D Diaz; S Moreno; J A López-Herce; E Bouza
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

7.  Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

Authors:  C Montalban; J L Calleja; A Erice; F Laguna; B Clotet; D Podzamczer; J Cobo; J Mallolas; M Yebra; A Gallego
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

8.  Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

Authors:  E N Janoff; J M Douglas; M Gabriel; M J Blaser; A J Davidson; D L Cohn; F N Judson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

9.  A pilot study of low-dose zidovudine in human immunodeficiency virus infection.

Authors:  A C Collier; S Bozzette; R W Coombs; D M Causey; D A Schoenfeld; S A Spector; C B Pettinelli; G Davies; D D Richman; J M Leedom
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

10.  Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey.

Authors:  M McLaughlin; P Thomas; I Onorato; A Rubinstein; J Oleske; S Nicholas; K Krasinski; P Guigli; W Orenstein
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

View more
  2 in total

1.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

Review 2.  Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

Authors:  P C Döller
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.